As per MRFR analysis, the Long Read Sequencing Market Size was estimated at 1.16 (USD Billion) in 2024. The Long Read Sequencing Market Industry is expected to grow from 1.52 (USD Billion) in 2025 to 17.48 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 31.20% during the forecast period (2025 - 2034). Increased demand for comprehensive genomic insights and the elucidation of complex genetic variations are the key market drivers enhancing market growth.
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
Market CAGR for long read sequencing is being driven by the expanding applications across various fields, facilitated by advancements in sequencing technologies and data analysis methods. Long read sequencing, characterized by its ability to generate longer DNA or RNA sequences compared to traditional short read sequencing methods, offers researchers unprecedented insights into complex genomic structures, including structural variations, repeat regions, and structural rearrangements. This trend is particularly evident in the field of genomics, where long read sequencing has revolutionized genome assembly, allowing for more accurate and comprehensive characterization of genomes, including those of non-model organisms and human individuals with complex genomic features.
Moreover, long read sequencing is increasingly being utilized in clinical and diagnostic settings, driving its adoption in precision medicine initiatives and personalized healthcare. The ability to capture long-range genomic information enables clinicians to identify disease-causing mutations, detect genetic predispositions to diseases, and tailor treatment strategies based on individual patient genomes. This trend is bolstered by the growing availability of long read sequencing platforms that offer high-throughput capabilities and streamlined workflows, making genomic analysis more accessible and cost-effective in clinical laboratories. Another key driver of growth in the long read sequencing market is the emergence of novel sequencing technologies and platforms characterized by improved read lengths, accuracy, and scalability. Companies are investing heavily in research and development to overcome technical challenges associated with long read sequencing, such as error rates and throughput limitations, leading to the introduction of next-generation sequencing platforms that promise enhanced performance and reliability. These technological advancements are expanding the applications of long read sequencing beyond basic research, enabling discoveries in fields such as agriculture, microbiology, and evolutionary biology.
Additionally, the growing demand for long read sequencing services and bioinformatics solutions is driving market expansion as researchers seek specialized expertise and computational resources to analyze and interpret large-scale genomic datasets. Bioinformatics tools and algorithms tailored for long read sequencing data are essential for genome assembly, variant calling, and functional annotation, enabling researchers to extract meaningful insights from complex genomic information. As a result, there is a rising demand for bioinformatics services and cloud-based platforms that offer scalable solutions for data storage, analysis, and visualization, driving growth in the long read sequencing market.
Furthermore, the integration of long read sequencing with complementary technologies, such as short read sequencing, optical mapping, and single-cell analysis, is driving innovation and synergy in genomic research. By combining multiple sequencing modalities, researchers can overcome the limitations of individual technologies and obtain comprehensive insights into genome structure, function, and regulation. This multi-omic approach is fueling interdisciplinary collaborations and driving demand for integrated sequencing solutions that offer a holistic view of biological systems. Thus, driving the Long Read Sequencing market revenue.
The Long Read Sequencing market segmentation, based on technique, includes Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Others. In 2023, the single-molecule real-time sequencing segment dominated the market due to its capability to generate exceptionally long reads, surpassing other sequencing methods in read length and accuracy. The SMRT technology, developed by Pacific Biosciences, enables researchers to capture complex genomic structures and accurately characterize structural variations with high sensitivity. Its unique capability to directly observe DNA synthesis in real-time provides researchers with invaluable insights into genome structure, function, and regulation, driving its widespread adoption across various fields. Further, nanopore sequencing is the fastest-growing segment in the market.
The Long Read Sequencing market segmentation, based on product, includes Instruments, Consumables, and Services. In 2023, the consumables category dominated the market due to their essential role in sample preparation, library construction, and sequencing workflows. These consumables include reagents, kits, and cartridges specifically designed for long read sequencing platforms, ensuring optimal performance and accuracy. As the demand for long read sequencing grows across various applications, there is a corresponding increase in the consumption of consumables required for sample processing and analysis. Further, the instruments are the second most dominant product in the market.
The Long Read Sequencing market segmentation, based on application, includes Research Application and Clinical Application. In 2023, the research application category will dominate the market due to the technology's ability to provide comprehensive and detailed insights into complex genomic structures. Researchers across various fields, including genomics, microbiology, and evolutionary biology, rely on long read sequencing to unravel intricate genomic features such as structural variations, repeat regions, and large-scale rearrangements. The technology's capacity to generate longer DNA or RNA sequences enables more accurate genome assembly and facilitates the identification of novel genetic elements and functional annotations. Further, clinical application is the fastest-growing category due to the rise in the prevalence of genetic disorders and chronic diseases.
Figure 1: Long Read Sequencing Market, by Application, 2023 & 2032 (USD Billion)
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
By region, the study gives market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Long Read Sequencing market area will dominate this market, owing to the availability of a strong informatics network and the well-established rules for approval and marketing of genomic testing products and services. Furthermore, the rising clinical and academic use of genomic techniques in the region boosts market growth.
Further, the prime countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, India, Japan, Australia, South Korea, and Brazil.
Figure 2: LONG READ SEQUENCING MARKET SHARE BY REGION 2023 (USD Billion)
Source: The Primary Research, Secondary Research, MRFR Database and Analyst Review
Europe's Long Read Sequencing market accounts for the second-largest market share because of the increasing adoption of long read sequencing technology across research institutions, academic laboratories, and clinical settings. Further, the German Long Read Sequencing market held the largest market share, and the UK Long Read Sequencing market was the fastest-growing market in the European region.
The Asia-Pacific Long Read Sequencing Market is expected to grow at the fastest CAGR from 2025 to 2034. This is due to the increasing investments in diagnostic techniques and penetration of primary market players. Moreover, China’s Long Read Sequencing market held the largest market share, and the Indian Long Read Sequencing market was the fastest-growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Long Read Sequencing market grow even more. Market players are also undertaking different strategic activities to spread their footprint, with important market developments including new product launches, mergers and acquisitions, contractual agreements, higher investments, and collaboration with other organizations. To expand and sustain in a more competitive and rising market climate, the Long Read Sequencing industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the primary business tactics utilized by manufacturers in the Long Read Sequencing industry to benefit clients and grow the market sector. In recent years, the Long Read Sequencing industry has provided some of the most significant benefits to medicine. Major players in the Long Read Sequencing market, including Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Limited, Element Biosciences, Quantapore, Inc., BGI Genomics, Eurofins Genomics, MicrobesNG, NextOmics, Stratos Genomics, Inc., and New England Biolabs, and others, are trying to raise market demand by investing in the research and development operations.
Pacific Biosciences is a renowned biotechnology company at the forefront of genomic sequencing technology. Established in 2004, the company has pioneered the development of long read sequencing platforms, offering researchers unparalleled insights into complex genomic landscapes. Pacific Biosciences' flagship product, the Sequel II System, enables high-throughput, single-molecule sequencing, facilitating comprehensive genome assembly and structural variant detection. Pacific Biosciences continues to advance genomic research and personalized medicine initiatives worldwide, empowering scientists and clinicians to unlock the mysteries of the genome and improve human health. In May 2022, Pacific Biosciences collaborated with iLAC and the Robotic Biology Institute, a Japanese organization, to investigate the automation of the sample preparation workflow for the Sequel II and IIe long read sequencing with the utilization of a robotic laboratory technician.
Oxford Nanopore Technologies is a prominent biotechnology company renowned for its innovative contributions to the field of DNA sequencing. Founded in 2005, the company specializes in the development and commercialization of nanopore-based sequencing platforms, offering portable, real-time DNA and RNA sequencing solutions. Oxford Nanopore's flagship product, the MinION, has revolutionized genomics research by providing researchers with the ability to perform sequencing experiments in diverse settings, from laboratories to remote locations. Their sequencing technology utilizes nanopores, which are nanometer-sized pores embedded in membranes, to detect and analyze nucleic acids as they pass through. In May 2022, Oxford Nanopore Technologies launched its GridION X5 system, a high-throughput long read sequencing platform. This system helps in the simultaneous sequencing of up to five flow cells, providing increased throughput and scalability for long read sequencing applications.
July 2022:Pacific Biosciences announced the introduction of its sequel, Ille System, the latest version of its long read sequencing platform. This system offers improved read length performance precision and throughput, allowing researchers to explore complex genomic regions with greater accuracy.
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others
Instruments
Consumables
Services
Research Application
Clinical Application
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2024 | 1.16 (USD Billion) |
| Market Size 2025 | 1.52 (USD Billion) |
| Market Size 2034 | 17.48 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 31.20 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Revenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Technique, Product, Application, and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, and Brazil |
| Key Companies Profiled | Pacific Biosciences of California, Inc., MicrobesNG, Oxford Nanopore Technologies Limited, Eurofins Genomics, Quantapore, Inc., Element Biosciences, BGI Genomics, Stratos Genomics, Inc., NextOmics, and New England Biolabs |
| Key Market Opportunities | Its application in clinical diagnostics and personalized medicine. |
| Key Market Dynamics | Increasing demand for comprehensive genomic analysis, particularly in research, clinical diagnostics, and precision medicine applications. |
Frequently Asked Questions (FAQ) :
The Long Read Sequencing market size was valued at USD 0.671 Billion in 2023.
The market is foreseen to rise at a CAGR of 31.20% during the forecast period, 2025-2034.
North America had the largest share of the market
The prime players in the market are Pacific Biosciences of California, Inc., Element Biosciences, Oxford Nanopore Technologies Limited, Quantapore, Inc., BGI Genomics, Eurofins Genomics, MicrobesNG, NextOmics, Stratos Genomics, Inc., and New England Biolabs.
The consumables category dominated the market in 2023.
The research application had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
